Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
Category Added in a WPeMatico Campaign
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.
A research team has recently developed a neuromorphic exposure control (NEC) system that enhances machine vision under extreme lighting variations.
If you hate the big camera bump of today’s smartphones, you’ll love the detachable lens of Xiaomi’s Modular Optical System.
If businesses fail to up their cybersecurity game, the systems everyone relies on could face serious and devastating disruptions.Read More
The company’s latest affordable smartphones are thinner and more durable and have a sprinkling of AI.
The price of GPT-4.5 is very steep. But it doesn’t mean that it’s a failure (or that it will always be so expensive).Read More
DOGE claims that a government agency has nearly three times as many software licenses as employees. Experts say there are plenty of good reasons for that.
This week on “Uncanny Valley,” our hosts talk about three big stories from February.
In rearchitecting the upgraded Alexa voice assistant, Amazon turned to model mixing to bring agentic capabilities to devices.Read More
More than 50 people have died in the Democratic Republic of the Congo, most within 48 hours of the onset of symptoms. Initial analysis suggests neither Ebola nor Marburg is the cause.